Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs SAMRAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA SAMRAT PHARMA SHUKRA PHARMA/
SAMRAT PHARMA
 
P/E (TTM) x 17.9 21.1 84.8% View Chart
P/BV x 4.5 2.1 213.5% View Chart
Dividend Yield % 1.7 0.2 748.6%  

Financials

 SHUKRA PHARMA   SAMRAT PHARMA
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-24
SAMRAT PHARMA
Mar-24
SHUKRA PHARMA/
SAMRAT PHARMA
5-Yr Chart
Click to enlarge
High Rs97604 16.1%   
Low Rs11320 3.5%   
Sales per share (Unadj.) Rs68.0911.3 7.5%  
Earnings per share (Unadj.) Rs16.97.0 241.6%  
Cash flow per share (Unadj.) Rs18.89.1 206.6%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Avg Dividend yield %1.80.2 854.6%  
Book value per share (Unadj.) Rs52.6210.3 25.0%  
Shares outstanding (eoy) m10.963.09 354.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.80.5 156.7%   
Avg P/E ratio x3.266.0 4.8%  
P/CF ratio (eoy) x2.950.8 5.7%  
Price / Book Value ratio x1.02.2 46.8%  
Dividend payout %5.914.3 41.4%   
Avg Mkt Cap Rs m5931,428 41.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5011 452.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7462,816 26.5%  
Other income Rs m2814 203.2%   
Total revenues Rs m7742,830 27.3%   
Gross profit Rs m19425 785.5%  
Depreciation Rs m216 316.8%   
Interest Rs m37 41.5%   
Profit before tax Rs m19925 789.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m134 376.0%   
Profit after tax Rs m18522 857.0%  
Gross profit margin %26.00.9 2,966.8%  
Effective tax rate %6.814.2 47.7%   
Net profit margin %24.90.8 3,236.6%  
BALANCE SHEET DATA
Current assets Rs m5621,026 54.8%   
Current liabilities Rs m142564 25.1%   
Net working cap to sales %56.416.4 344.2%  
Current ratio x4.01.8 218.5%  
Inventory Days Days011 0.0%  
Debtors Days Days1,200898 133.6%  
Net fixed assets Rs m216192 112.7%   
Share capital Rs m10931 354.3%   
"Free" reserves Rs m467619 75.4%   
Net worth Rs m576650 88.7%   
Long term debt Rs m270-   
Total assets Rs m7781,217 63.9%  
Interest coverage x70.84.7 1,515.9%   
Debt to equity ratio x00-  
Sales to assets ratio x1.02.3 41.4%   
Return on assets %24.22.3 1,033.0%  
Return on equity %32.23.3 966.6%  
Return on capital %33.44.9 677.9%  
Exports to sales %02.0 0.0%   
Imports to sales %083.5 0.0%   
Exports (fob) Rs mNA58 0.0%   
Imports (cif) Rs mNA2,350 0.0%   
Fx inflow Rs m058 0.0%   
Fx outflow Rs m02,350 0.0%   
Net fx Rs m0-2,293 -0.0%   
CASH FLOW
From Operations Rs m-5294 -55.2%  
From Investments Rs m-12-4 295.8%  
From Financial Activity Rs m124-112 -110.7%  
Net Cashflow Rs m60-22 -273.7%  

Share Holding

Indian Promoters % 51.0 49.0 104.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 3.2 3.4%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 51.1 96.1%  
Shareholders   16,321 6,984 233.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on RELISH PHARMA vs SAMRAT PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs SAMRAT PHARMA Share Price Performance

Period RELISH PHARMA SAMRAT PHARMA S&P BSE HEALTHCARE
1-Day 1.06% -1.21% 1.23%
1-Month -11.94% -7.35% -0.24%
1-Year 165.72% 17.79% 43.62%
3-Year CAGR 172.08% 22.75% 20.35%
5-Year CAGR 84.67% 36.81% 26.24%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the SAMRAT PHARMA share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of SAMRAT PHARMA the stake stands at 49.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of SAMRAT PHARMA.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 5.9%.

SAMRAT PHARMA paid Rs 1.0, and its dividend payout ratio stood at 14.3%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of SAMRAT PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.